{"id":"W4239531242","doi":"10.2165/00128413-200414290-00064","title":"The Therapeutic Products Directorate of Health Canada has approved gemifloxacin","year":2004,"lang":"en","type":"article","venue":"Inpharma Weekly","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"ca_institutions":"","funders":"","keywords":"Gemifloxacin; Medicine; Pharmacy; Environmental health; Family medicine; Moxifloxacin; Microbiology; Antibiotics","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004579984,0.0004391793,0.0007143231,0.001534028,0.001660765,0.001975611,0.00120852,0.003964651,0.01986388],"category_scores_gemma":[0.009384239,0.0003627396,0.001004557,0.001182581,0.0009396999,0.0004517749,0.000407112,0.002962639,0.003795016],"about_ca_system_candidate":true,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.01173801,"about_ca_system_score_gemma":0.05123117,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.4322423,"about_ca_topic_score_gemma":0.696483,"domain_scores_codex":[0.996687,0.0008136004,0.0001684154,0.0001495448,0.001536539,0.0006450276],"domain_scores_gemma":[0.9835141,0.002074661,0.001063193,0.0003528502,0.01035699,0.002638243],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.003065146,0.0004777908,0.01487906,0.0007161547,0.0001216978,0.0008844021,0.0001174788,0.0005045605,0.008917185,0.004543911,0.7331522,0.2326204],"study_design_scores_gemma":[0.0006778891,0.001005295,0.01826075,0.0002469806,0.0001523758,0.0006080907,0.0001240894,0.0007503233,0.006600969,0.0002693966,0.9712625,0.00004127813],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"other","genre_gemma":"other","genre_scores_codex":[0.08570343,0.05670136,0.008140403,0.3617911,0.01697405,0.002964789,0.02534005,0.002247048,0.4401378],"genre_scores_gemma":[0.3197269,0.02147801,0.01197886,0.06577463,0.004259257,0.000303577,0.01138892,0.000359927,0.5647299],"genre_candidate":"other","genre_consensus":"other","teacher_disagreement_score":0.988262,"threshold_uncertainty_score":0.8594528,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.3939423323082523,"score_gpt":0.4025350128563726,"score_spread":0.008592680548120346,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}